Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JPO2/CDCA7L and LEDGF/p75 Are Novel Mediators of PI3K/AKT Signaling and Aggressive Phenotypes in Medulloblastoma.

Cancer research - 1 May 2016

Chan Tiffany Sin Yu, Hawkins Cynthia, Krieger Jonathan R, McGlade C Jane, Huang Annie

Abstract excerpt

Substantial evidence links Myc-PI3K/AKT signaling to the most aggressive subtype of medulloblastoma and this axis in medulloblastoma therapy. In this study, we advance understanding of how Myc-PI3K/AKT signaling contributes to this malignancy, specifically, in identifying the Myc-interacting protein JPO2 and its partner binding protein LEDGF/p75 as critical modulators of PI3K/AKT signaling and metastasis in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mice, Nude
Share to Medulloblastoma
Share to Adaptor Proteins, Signal Transducing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cerebellar Neoplasms

Share to Heterografts

Share to Mass Spectrometry

Share to Phosphatidylinositol 3-Kinases

Share to Proto-Oncogene Proteins c-akt

Source

Identifiers

PMID: 27013196
DOI: 10.1158/0008-5472.CAN-15-2194

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

JPO2/CDCA7L and LEDGF/p75 Are Novel Mediators of PI3K/AKT Signaling and Aggressive Phenotypes in Medulloblastoma.PMID 27013196Read ↗

Identification of a Novel c-Myc Protein Interactor, JPO2, with Transforming Activity in Medulloblastoma CellsSemantic proximity Read ↗

Molecular Determinants of Medulloblastoma Metastasis and Leptomeningeal DisseminationSemantic proximity Read ↗

Integrated Analysis of Transcriptome Data Revealed AURKA and KIF20A as Critical Genes in Medulloblastoma ProgressionSemantic proximity Read ↗

Targeting the PI3K/AKT/mTOR Signaling Pathway in MedulloblastomaSemantic proximity Read ↗

Regulatory effects of a Mnk2-eIF4E feedback loop during mTORC1 targeting of human medulloblastoma cellsSemantic proximity Read ↗

Polo-like kinase 4 mediates epithelial–mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathwaySemantic proximity Read ↗

Cdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastomaSemantic proximity Read ↗

A Kinome-Wide RNAi Screen in Drosophila Glia Reveals That the RIO Kinases Mediate Cell Proliferation and Survival through TORC2-Akt Signaling in GlioblastomaSemantic proximity Read ↗

Aberrant JmjC domain-containing protein 8 (JMJD8) expression promotes activation of AKT and tumor epithelial-mesenchymal transition.Semantic proximity Read ↗

A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven MedulloblastomaSemantic proximity Read ↗

Expression of the Stress Response Oncoprotein LEDGF/p75 in Human Cancer: A Study of 21 Tumor TypesSemantic proximity Read ↗

Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.